Delivery Order SPE2DE24D0021-SPE2D626F450K
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract by the Department of Defense Medical Supply Chain for a Kit RT PCR RNA DNA Polymer with a ceiling value of $1,604.00. The award was issued on October 30, 2025, with an ultimate completion date of November 14, 2025. This fixed-price contract with economic price adjustment represents a child contract under a larger procurement vehicle and involves no set-aside designation, indicating competition in an open federal...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,167.00 by the Department of Defense's Medical Supply Chain for RGT RT PCR ROX AGPATH-ID ARRAYSCRIPT AMP diagnostic products. Awarded on November 5, 2025, with an ultimate completion date of November 21, 2025, this fixed-price contract with economic price adjustment represents a child order under a larger procurement vehicle. The award carries no set-aside designation, indicating Fisher Scientific competed in an...
- Fisher Scientific Company L.L.C. received a delivery order valued at $28,623.50 from the Department of Defense Medical Supply Chain for System PCR IV 1st Strain Superscript 50 Reaction kits, with an ultimate completion date of November 20, 2025. This fixed-price contract with economic price adjustment was awarded on November 5, 2025, with no set-aside designation, indicating open competition. The supplies will be delivered to Pittsburgh, Pennsylvania. This delivery order represents a child...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,560.26 by the Department of Defense's Medical Supply Chain for RT-PCR reverse transcriptase reagents with reduced ribonuclease activity, with a final completion date of December 19, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, indicating competition in an open federal procurement environment. The contract represents a child order under a larger vehicle,...
- Fisher Scientific Company L.L.C. has been awarded a $2,346.48 delivery order contract (Contract No. 4568797735) for MAGMAX Viral/Pathogen products by the Defense Department's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority is scheduled for completion by August 5, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made on July 15, 2025, without any set-aside designation, reflecting Fisher Scientific's ability to compete...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $1,952.64 to Fisher Scientific Company L.L.C. for direct polymerase chain reaction (PCR) reagents and kits, specifically MagMAX DNA products. This fixed-price delivery order with economic price adjustment was issued on November 4, 2025, with an ultimate completion date of November 17, 2025, and will be performed in Pittsburgh, Pennsylvania. The award carries no set-aside designation, indicating competition...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,433.64 for DNA extraction and purification supplies utilizing the MagMAX technology platform. The contract, awarded on June 17, 2025, with an ultimate completion date of June 25, 2025, is funded by the Medical Supply Chain division of the Department of Defense. This delivery order represents a child contract with fixed pricing that includes economic price adjustment provisions, and no set-aside designation was utilized in...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,433.64 for DNA extraction and purification products utilizing the MagMAX technology platform. The contract, issued by the Defense Medical Supply Chain on August 6, 2025, represents a fixed-price agreement with economic price adjustment provisions and is scheduled for completion by August 13, 2025. The work will be performed in Pittsburgh, Pennsylvania. This delivery order is issued under a larger contract vehicle and...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,978.75 for the MAGMAX+ DNA Multi-Sample Ultra 2.0 Kit, a molecular biology reagent product, with an ultimate completion date of December 12, 2025. This fixed-price delivery order with economic price adjustment was issued by the Defense Department's Medical Supply Chain function on December 6, 2025, with performance to take place in Pittsburgh, Pennsylvania. The award carries no set-aside designation, indicating...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order contract to Fisher Scientific Company L.L.C. on August 6, 2025, for direct polymerase chain reaction (PCR) reagents and kits, specifically MagMAX DNA products. This fixed-price delivery order with economic price adjustment carries a ceiling value of $1,952.64 and is scheduled for completion by August 18, 2025. The performance location is Pittsburgh, Pennsylvania. This award represents a child contract under a larger...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F450KDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,952.64 for direct PCR reagents and kits, specifically MagMAX DNA products, by the Department of Defense's Medical Supply Chain. The award, issued on November 24, 2025, represents a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of December 5, 2025. The contract is not designated as a set-aside procurement and will be performed in Pittsburgh, Pennsylvania, where Fisher Scientific maintains its principal place of business. This delivery order is a child contract under a larger indefinite delivery vehicle, enabling the Medical Supply Chain to procure specialized laboratory diagnostic supplies on an as-needed basis. Fisher Scientific, a for-profit limited liability company registered in the System for Award Management since July 2001, has established itself as a critical supplier of scientific products, laboratory equipment, and medical supplies across multiple federal agencies. The company's extensive federal contract portfolio includes significant work with the Department of Veterans Affairs and the Department of Defense, delivering specialized laboratory instruments, diagnostic equipment, and reagents supporting research, healthcare delivery, and diagnostic operations. The modest ceiling value of this particular delivery order reflects routine consumable procurement, consistent with Fisher Scientific's demonstrated capability to reliably supply laboratory reagents and diagnostic products supporting federal healthcare and research operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/23/25 |